NF-κB signaling pathway, not IFN-β/STAT1, is responsible for the selenium suppression of LPS-induced nitric oxide production

被引:33
作者
Yun, Cheol-Heui
Yang, Jae Seung
Kang, Seok-Seong
Yang, Young
Cho, Jung Hyo
Son, Chang Gue
Han, Seung Hyun [1 ]
机构
[1] Seoul Natl Univ, Sch Dent, Dept Oral Microbiol & Immunol, Seoul 110749, South Korea
[2] Seoul Natl Univ, Sch Dent, Dent Res Inst, Seoul 110749, South Korea
[3] Seoul Natl Univ, Sch Agr Biotechnol, Seoul 151742, South Korea
[4] Seoul Natl Univ Res Park, Int Vaccine Inst, Seoul 151818, South Korea
[5] Sookmyung Womens Univ, Ctr Res Womens Dis, Dept Life Sci, Seoul 140742, South Korea
[6] Daejon Univ, Dunsan Oriental Hosp, E W Canc Ctr, Taejon 301724, South Korea
关键词
selenium; nitric oxide; toll-like receptor; NF-kappa B; lipopolysaccharide; macrophage;
D O I
10.1016/j.intimp.2007.05.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Upon stimulation of macrophages with lipopolysaccharide (LPS), Toll-like receptor 4 recognizes LPS, leading to expression of inducible nitric oxide synthase (iNOS), via MyD88/NF-KB and TRIF/IFN-beta/STAT pathways. Although selenium (Se) was reported to inhibit nitric oxide (NO) production, it is unclear which signaling pathway is inhibited by Se. Here, we investigated how Se inhibits NO production in LPS-stimulated RAW 264.7 cells. When the cells were pretreated with Se for I h followed by LPS treatment, iNOS mRNA expression and subsequent NO production declined significantly in a dose-dependent manner. Se inhibited IKB alpha degradation in the cytosol and NF-KB binding to its recognition site in the nucleus of the LPS-stimulated cells. Meanwhile, Se did not inhibit IFN-beta mRNA induction or STAT1 phosphorylation in the LPS-stimulated cells. These results suggest that Se down-regulates iNOS gene expression and NO production in the LPS-stimulated macrophages through inhibition of the NF-KB activation pathway but not the IFN-beta/STAT1 signaling pathway. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:1192 / 1198
页数:7
相关论文
共 34 条
  • [1] Toll-like receptor signalling
    Akira, S
    Takeda, K
    [J]. NATURE REVIEWS IMMUNOLOGY, 2004, 4 (07) : 499 - 511
  • [2] Responsiveness of selenoproteins to dietary selenium
    Allan, CB
    Lacourciere, GM
    Stadtman, TC
    [J]. ANNUAL REVIEW OF NUTRITION, 1999, 19 : 1 - 16
  • [3] Armand-Ugón M, 2003, ANTIVIR THER, V8, P1
  • [4] Administration of the nitric oxide synthase inhibitor NG-Methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis:: Results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002)
    Bakker, J
    Grover, R
    McLuckie, A
    Holzapfel, L
    Andersson, J
    Lodato, R
    Watson, D
    Grossman, S
    Donaldson, J
    Takala, J
    [J]. CRITICAL CARE MEDICINE, 2004, 32 (01) : 1 - 12
  • [5] Science, medicine, and the future - Pathogenesis of sepsis: new concepts and implications for future treatment
    Bochud, PY
    Calandra, T
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2003, 326 (7383): : 262 - 266
  • [6] Role of Se-dependent glutathoine peroxidases in gastrointestinal inflammation and cancer
    Chu, FF
    Esworthy, RS
    Doroshow, JH
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2004, 36 (12) : 1481 - 1495
  • [7] Chemopreventive mechanisms of selenium
    Combs, GF
    [J]. MEDIZINISCHE KLINIK, 1999, 94 (Suppl 3) : 18 - 24
  • [8] Is nitric oxide overproduction the target of choice for the management of septic shock?
    Feihl, F
    Waeber, B
    Liaudet, L
    [J]. PHARMACOLOGY & THERAPEUTICS, 2001, 91 (03) : 179 - 213
  • [9] Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase
    Ganther, HE
    [J]. CARCINOGENESIS, 1999, 20 (09) : 1657 - 1666
  • [10] Selenium in critical illness
    Geoghegan, M
    McAuley, D
    Eaton, S
    Powell-Tuck, J
    [J]. CURRENT OPINION IN CRITICAL CARE, 2006, 12 (02) : 136 - 141